Affiliation: University of Maryland
- Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysisElaine Weiner
The Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, USA
J Clin Psychiatry 73:95-102. 2012..To clarify the efficacy and tolerability of bupropion sustained release (SR) for the treatment of cigarette smoking in people with schizophrenia...
- Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophreniaE Weiner
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland at Baltimore, P O Box 21247, Baltimore, MD 21228, USA
Am J Psychiatry 158:635-7. 2001..The study examined the efficacy, tolerability, and safety of supportive group psychotherapy and adjunctive sustained-release bupropion for nicotine addiction in patients with schizophrenia...
- Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year studyD L Kelly
Maryland Psychiatric Research Center, University of Maryland, Baltimore, MD, USA
J Psychopharmacol 23:436-41. 2009..Future studies should aim to relate remission criteria to functional outcomes, cognition, and other important symptom domains...